supplier
Qdem Pharmaceuticals Limited
Qdem Pharmaceuticals Limited has won 7 UK public sector awards from 3 buyers since 2020. The typical award is worth £12,327,097.
as a supplier
7 recorded awards from 3 buyers , between 21 Dec 2020 and 23 Apr 2023.
“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.
sells to
| buyer | awards |
|---|---|
| NHS England | 5 |
| The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") | 1 |
| The NHS Commissioning Board (operating under the name of NHS England) | 1 |
common questions about Qdem Pharmaceuticals Limited
How many public sector contracts has Qdem Pharmaceuticals Limited won?
- Qdem Pharmaceuticals Limited has won 7 UK public sector contracts from 3 public bodies since 2020.
Which public bodies buy from Qdem Pharmaceuticals Limited?
- Qdem Pharmaceuticals Limited has won the most contracts from NHS England, The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") and The NHS Commissioning Board (operating under the name of NHS England).
How large are Qdem Pharmaceuticals Limited's contracts?
- The median published value of a contract won by Qdem Pharmaceuticals Limited is £12,327,097. Framework ceilings are excluded, because they state a spending limit shared across many suppliers rather than a value one supplier received.
contracts won
| contract | buyer | value | awarded |
|---|---|---|---|
| NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals shared | NHS England | £304,504,000 | 23 Apr 2023 |
| NHS Framework Agreement for Branded Medicines - National shared | NHS England | £95,224,871 | 26 Sept 2021 |
| NHS National Generic Pharmaceuticals Interim 2 shared | NHS England | £12,327,097 | 21 Dec 2020 |
| NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines shared | The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") | · | 6 Jan 2026 |
| NHS Framework Agreement for Branded Medicines - National Proprietary Pharmaceuticals shared | NHS England | · | 6 Apr 2023 |
| NHS Framework Agreement for Branded Medicines - National shared | NHS England | · | 28 May 2021 |
| NHS National Generic Pharmaceuticals Interim 2 2020 shared | The NHS Commissioning Board (operating under the name of NHS England) | · | 3 Feb 2021 |
every contract won by Qdem Pharmaceuticals Limited →
where these figures come from
Every figure on this page is derived from notices published by Contracts Finder, Find a Tender, Public Contracts Scotland and Sell2Wales, under the Open Government Licence v3.0. The corpus runs from 17 Dec 2014 to 13 Sept 2026 and is refreshed from the publishers' own APIs through the working day.
Records are combined into one organisation on identifiers where publishers provide them — a Companies House number, a GB-PPON supplier id — and on exact normalised name and address where they do not. Never on address alone: one shared-service postcode carries 244 unrelated organisations.
Counts are of contracting processes, not published notices: a tender and its award notice are one contract, and are counted once. Values are medians, never totals, and exclude framework ceilings — a ceiling states a spending limit shared across every supplier on the framework, so adding them together produces a number no one ever spent. sources and coverage · how matching works
Contains public sector information licensed under the Open Government Licence v3.0.